Product Information
DICYCLOMINE 10 MG/5 ML SOLN is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1736 per ML under NDC 00054062263. Its NADAC has been published 328 times since Jun 24, 2020.
FDA first approved this application on May 22, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
10 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054062263
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212286FDA Approved
5/22/2020
TE Code
AA
On Market Since
5/22/2020
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 10 MG/5 ML SOLN has been published 328 times since Jun 24, 2020, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1736 per ML |
|---|---|
| All-time high | $0.2213 (Jul 14, 2021) |
| All-time low | $0.1409 (Jul 17, 2024) |
| 52-week high | $0.1868 |
| 52-week low | $0.1736 |
| Median price | $0.1940 |
| Average price | $0.1941 |
| Largest weekly change | +31.1% (Sep 20, 2023) |
| Weeks tracked | 328 |
| Tracking since | Jun 24, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dicyclomine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 10 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 10 MG/5 ML SOLN, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1736 per ML (NDC 00054062263), effective Sep 30, 2026.
How has the price of DICYCLOMINE 10 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 10 MG/5 ML SOLN has declined 19.7%. It has been tracked across 328 weekly CMS publications since Jun 24, 2020.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 10 MG/5 ML SOLN?
Since Jun 24, 2020, the NADAC for DICYCLOMINE 10 MG/5 ML SOLN has ranged from a low of $0.1409 (Jul 17, 2024) to a high of $0.2213 (Jul 14, 2021), with a median of $0.1940 per ML.
Are there cheaper alternatives to DICYCLOMINE 10 MG/5 ML SOLN?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICYCLOMINE 10 MG/5 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures DICYCLOMINE 10 MG/5 ML SOLN?
DICYCLOMINE 10 MG/5 ML SOLN (NDC 00054062263) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.